Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China

Wang, A; Yun, YH; Wen, ZH; Gao, YX; Qi, SZ; Zhang, Y; Liang, YS; Yao, X

Zhang, Y; Yao, X (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Dept Allergy & Rheumatol, 12 Jiangwangmiao St, Nanjing, Jiangsu, Peoples R China.;Liang, YS (通讯作者)，Southern Med Univ, Dermatol Hosp, Dept Dermatol, 2 Lujing Rd, Guangzhou 510091, Peoples R China.

WORLD ALLERGY ORGANIZATION JOURNAL, 2022; 15 (12):

Abstract

Background: Omalizumab is an effective treatment for chronic spontaneous urticaria (CSU) patients aged >12 years, but its efficacy in patients aged......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索